In summary, evidence is mounting that anti-U11/U12 (RNPC-3) antibodies represent a rare but important antibody specificity as they often occur in the absence of other SSc-related antibodies and are detected in patients with ILD [36]. This evidence concerns the gene RNU12-2P and interstitial lung disease.